Insilico Opens AI Toolkit for Global Longevity Research
Abu Dhabi, UAE, September 17, 2026 Insilico Medicine has announced the global opening of its AI-powered longevity discovery toolkit,...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Device Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Abu Dhabi, UAE, September 17, 2026 Insilico Medicine has announced the global opening of its AI-powered longevity discovery toolkit,...
New York, New York, September 17, 2026 Inductive Bio has launched Beacon-2, a new artificial intelligence system designed to...
San Diego, California, and Austin, Texas, September 17, 2026 Aethlon Medical, Inc. and North Immunology, Inc. have announced a...
Plainsboro, New Jersey, and Bagsværd, Denmark, September 17, 2026 Novo Nordisk has announced published Phase 3b results from the...
